Slowly, but surely, the U.S. Drug Enforcement Administration is rolling out licenses to entities that want federal permission to grow cannabis for research. For more than fifty years, only one place could legally do so: the University of Mississippi. Then in 2016, the...

A recent op-ed concerning high-potency cannabis products opened with: “As more of us reveal our stories, more families are empowered to share theirs, as well.” That inspired me to share my family’s story. Access to therapeutically concentrated cannabis saved my life....

PHARMACEUTICALRX, one of the largest producers of premium organic medical marijuana products in the US market, today announced that it has closed a $34 million senior secured term loan (the “Senior Term Loan”) provided by Chicago Atlantic Real Estate Finance,...

Marijuana is the most used illicit substance globally, with roughly 90 million individuals in Europe alone having used the drug once in their lifetime. Recently, scientists from the Karolinska Institute in Stockholm conducted a study to determine whether changes in...

Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses to grow, research, develop, and manufacture alternative drugs derived from cannabis (marijuana) and other botanicals in December 2021. REP is the first-of-its-kind...

News Royal Emerald Pharmaceuticals (REP) Receives Federal Licenses For Cannabis Research By The company received 4 licenses to grow, research, develop, and manufacture Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses...